Provision of KEL1-negative blood to obstetric patients: A 3-year single-institution retrospective review

Transfusion

Volumn 55, Issue 3, 2015, Pages 599-604

  O'Brien, Kerry L ^a,b   Kim, Yeowon A ^b   Haspel, Richard L ^a,b   Uhl, Lynne ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLOIMMUNIZATION; ARTICLE; BLOOD DONOR; BLOOD GROUP KELL SYSTEM; ERYTHROCYTE TRANSFUSION; EVALUATION STUDY; FEMALE; HEALTH CARE POLICY; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MATERNITY WARD; MEDICAL RECORD REVIEW; MIDDLE AGED; NEWBORN HEMOLYTIC DISEASE; OBSTETRIC PATIENT; PROTOCOL COMPLIANCE; RETROSPECTIVE STUDY; BLOOD; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUP TYPING; ERYTHROBLASTOSIS, FETAL; IMMUNIZATION; IMMUNOLOGY; NEWBORN; OPERATIVE BLOOD LOSS; POLICY; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY COMPLICATIONS; PREVALENCE; UNITED STATES; UNNECESSARY PROCEDURE; UTERINE HEMORRHAGE; YOUNG ADULT;

BLOOD GROUP KELL SYSTEM; KEL PROTEIN, HUMAN; MEMBRANE PROTEIN; METALLOPROTEINASE;

ADULT; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUPING AND CROSSMATCHING; BLOOD LOSS, SURGICAL; BOSTON; ERYTHROBLASTOSIS, FETAL; ERYTHROCYTE TRANSFUSION; FEMALE; GUIDELINE ADHERENCE; HUMANS; IMMUNIZATION; INFANT, NEWBORN; KELL BLOOD-GROUP SYSTEM; MEMBRANE GLYCOPROTEINS; METALLOENDOPEPTIDASES; MIDDLE AGED; ORGANIZATIONAL POLICY; PREGNANCY; PREGNANCY COMPLICATIONS; PREVALENCE; RETROSPECTIVE STUDIES; UNNECESSARY PROCEDURES; UTERINE HEMORRHAGE; YOUNG ADULT;

EID: 84924534440     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12814     Document Type: Article

References (19)

1. Westhoff CM, Reid ME,. Review: the Kell, Duffy, and Kidd blood group systems. Immunohematology 2004; 20: 37-49.
2. Daniels G,. Other blood groups. In:, Roback JD, Grossman BJ, Harris T, et-al., editors. Technical manual. 17th ed. Bethesda (MD): American Association of Blood Banks; 2011. p. 411-436.
3. Geifman-Holtzman O, Wojtowycz M, Kosmas E, et-al. Female alloimmunization with antibodies known to cause hemolytic disease. Obstet Gynecol 1997; 89: 272-275.
4. van der Schoot CE, Tax GH, Rijnders RJ, et-al. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed. Transfus Med Rev 2003; 17: 31-44.
5. Caine ME, Mueller-Heubach E,. Kell sensitization in pregnancy. Am J Obstet Gynecol 1986; 154: 85-90.
6. Klein HG, Anstee DJ,. Haemolytic disease of the fetus and newborn. In:, Klein HG, Anstee DJ, editors. Mollison's blood transfusion in clinical medicine. 11th ed. Malden (MA): Blackwell Publishing Ltd; 2005. p. 526-527.
7. Bowman JM, Pollock JM, Manning FA, et-al. Maternal Kell blood group alloimmunization. Obstet Gynecol 1992; 79: 239-244.
8. van Wamelen DJ, Klumper FJ, de Haas M, et-al. Obstetric history and antibody titer in estimating severity of Kell alloimmunization in pregnancy. Obstet Gynecol 2007; 109: 1093-1098.
9. Vaughan JI, Manning M, Warwick RM, et-al. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N Engl J Med 1998; 338: 798-803.
10. Vaughan JI, Warwick R, Letsky E, et-al. Erythropoietic suppression in fetal anemia because of Kell alloimmunization. Am J Obstet Gynecol 1994; 171: 247-252.
11. Weiner CP, Widness JA,. Decreased fetal erythropoiesis and hemolysis in Kell hemolytic anemia. Am J Obstet Gynecol 1996; 174: 547-551.
12. Santiago JC, Ramos-Corpas D, Oyonarte S, et-al. Current clinical management of anti-Kell alloimmunization in pregnancy. Eur J Obstet Gynecol Reprod Biol 2008; 136: 151-154.
13. Farr V, Gray E,. Pregnancy outcome in mothers who develop Kell antibodies. Scott Med J 1988; 33: 300-303.
14. Grant SR, Kilby MD, Meer L, et-al. The outcome of pregnancy in Kell alloimmunisation. BJOG 2000; 107: 481-485.
15. McKenna DS, Nagaraja HN, O'Shaughnessy R,. Management of pregnancies complicated by anti-Kell isoimmunization. Obstet Gynecol 1999; 93 (5 Pt 1): 667-673.
16. Mayne KM, Bowell PJ, Pratt GA,. The significance of anti-Kell sensitization in pregnancy. Clin Lab Haematol 1990; 12: 379-385.
17. Van Kamp IL, Klumper FJ, Oepkes D, et-al. Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization. Am J Obstet Gynecol 2005; 192: 171-177.
18. Westhoff CM,. Molecular genotyping for RHD: what (not) to do? Transfusion 2007; 47: 1337-1339.
19. Kacker S, Frick KD, Tobian AA,. Data and interpretation: economic evaluations in transfusion medicine, Part 4. Transfusion 2014; 53: 2130-2133.